公司資料
Immunome 股價、新聞與催化劑
- 股票代碼:
- IMNM
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
28.08 USD (-5.85%)
收盤價
最後更新: 2026年8月20日
2.19B USD
市值
股價為何變動
As of Aug 20, 2026, IMNM closed down 5.85% at $28.08. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Immunome is a biotechnology company focused on antibody discovery and oncology, with a platform that seeks to translate immune recognition into therapeutic programs. Its story is about building value from discovery engines and targeted cancer biology.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Immunome sits in specialty biotechnology.
商業模式特徵
The company depends on platform validation, clinical progress, and the ability to create differentiated oncology assets.
生技產業定位
Immunome is a platform oncology name whose valuation is sensitive to translational and strategic progress.
未來催化劑
- Immunome’s catalysts are its antibody-discovery platform and oncology pipeline, especially any update that shows the company can still produce differentiated assets. The next readout matters because the platform still needs to prove itself.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。